Blog

Like many growth stocks, 2022 was a brutal year for most cannabis stocks. The Advisor Shares Pure Cannabis ETF and TFMG Alternative Harvest ETF are down more than 72% and 62%, respectively, at the

Block (NYSE: SQ), formerly known as Square, reported gross profit of slightly under $1.6 billion in its third quarter of 2022, which ended Sept. 30. Thats up 38% from the prior-year period. Its two

When Netflix (NASDAQ: NFLX) reports its fourth-quarter results in a few weeks, one familiar piece of information will be missing: its subscriber-growth expectations.

Investors have leaned heavily on

Happy New Year to all Social Security recipients. Some significant relief for your inflation-hit pocketbooks is on the way.

An 8.7% cost-of-living adjustment (COLA) is about to go into effect. There

Not much has gone right for growth stocks this year. A bear market has mauled the valuations of many once high-flying stocks.

However, a new year just might bring better news if analysts are right

If there's anything that 2022 has taught us as investors, it's that we always need to be aware of the risk factors in the broader macro environment, and also think about how they might impact

There are a lot of factors that investors need to consider when looking at a dividend stock. Yield is frankly just one small piece of the puzzle, even though many on Wall Street quickly get enamored

There's no cookie-cutter number regarding how much someone should have saved for retirement, but one thing is for certain: It's better to have too much saved than not enough. One of the best tools

Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) stock was closing out 2022 in positive territory and doing better than the S&P 500. This outperformance is largely due to investors preferring value

Apple's (NASDAQ: AAPL) stock declined nearly 30% in 2022 as investors fretted over the tech giant's persistent supply chain issues in China. A lack of clarity regarding its roadmap beyond the aging

If you thought Wall Street had a bad year, take a closer look at how the cryptocurrency space has fared. Based on data from CoinMarketCap.com, the aggregate value of more than 22,100 digital

Let's not mince words here: VF Corporation (NYSE: VFC) has had a terrible 2022. The parent company of well-known footwear and apparel brands like Vans, the North Face, Timberland, Dickies, and

The events of the 2022 stock market have left many investors feeling discouraged and perhaps unsure about what the new year could hold. While there is no guarantee that the volatility will abate in

Whether you have personal experience with cosmetic surgery or not, this corner of the economy is probably larger than you imagine. Grandview Research recently valued the global cosmetic surgery and

Investors did not have a fun year in 2022. But few struggled more than Cathie Wood and her company Ark Invest, which oversees a number of exchange-traded funds (ETFs) highly focused on the growth

Unless you're a short-seller or were invested heavily in energy stocks, 2022 was probably a struggle from an investment standpoint. The ageless Dow Jones Industrial Average, benchmark S&P 500, and

Social Security is one of these programs that has a lot of rules. But you know what they say about rules -- they aren't always set in stone.

This is definitely the case for Social Security. In fact

The stock market couldn't resist giving investors a parting shot on Friday, posting losses on the last day of the year. However, despite finishing lower by between 0.1% and 0.25%, major market

BioNTech (NASDAQ: BNTX), a company that rose to great prominence and a high stock price during the coronavirus pandemic, wasn't much of a star in the past few sessions on the stock market.

According

Arqit Quantum (NASDAQ: ARQQ) stock didn't end 2022 on a high note. In the last trading week of the year, the next-generation computing company's share price tumbled by 14%, according to data

Regularly adding money to stocks can be one of the smartest financial moves you make. The popular market barometer, the S&P 500 index, has returned 11% per year since 1950, which includes several

Biotech investors live for the day when one of their companies gets an investigational therapy approved. That happy circumstance occurred very recently for TG Therapeutics (NASDAQ: TGTX); as a

As market pundits repeatedly beat the "recession 2023" drum, investors might be tempted to delay buying high-conviction names on their watch lists. Yet there has already been a mini-recession in the

If you are old enough, you remember a time when the internet didn't exist. You probably wouldn't want to go back, and no one who has grown up with the technology would want to get rid of it

Growth stocks aren't delivering close to the mouthwatering returns they were for investors a few years ago, but that doesn't mean that the best days for these kinds of companies are in the past. On